Ct-based intratumoral and peritumoral radiomics for predicting prognosis in osteosarcoma: A multicenter study

被引:2
|
作者
Su, Qiushi [1 ]
Wang, Ning [2 ]
Wang, Bingyan [3 ]
Wang, Yanmei [4 ]
Dai, Zhengjun [5 ]
Zhao, Xia [6 ]
Li, Xiaoli [1 ]
Li, Qiyuan [1 ]
Yang, Guangjie [7 ]
Nie, Pei [1 ]
机构
[1] Qingdao Univ, Affiliated Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China
[2] Shandong First Med Univ, Shandong Prov Hosp, Dept Radiol, Jinan, Shandong, Peoples R China
[3] Qingdao Univ, Dept Ultrasound, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[4] GE Healthcare, Shanghai, Peoples R China
[5] Huiying Med Technol Co Ltd, Sci Res Dept, Beijing, Peoples R China
[6] Shandong Univ Tradit Chinese Med, Affiliated Hosp, Dept Radiol, Jinan, Shandong, Peoples R China
[7] Qingdao Univ, Dept Nucl Med, Affiliated Hosp, Qingdao, Shandong, Peoples R China
关键词
Osteosarcoma; Prognosis; Radiomics; Computerized tomography; METASTATIC OSTEOSARCOMA; SURVIVAL; NOMOGRAM;
D O I
10.1016/j.ejrad.2024.111350
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the performance of CT -based intratumoral, peritumoral and combined radiomics signatures in predicting prognosis in patients with osteosarcoma. Methods: The data of 202 patients (training cohort:102, testing cohort:100) with osteosarcoma admitted to the two hospitals from August 2008 to February 2022 were retrospectively analyzed. Progression free survival (PFS) and overall survival (OS) were used as the end points. The radiomics features were extracted from CT images, three radiomics signatures(RS intratumoral, RS peritumoral, RS combined)were constructed based on intratumoral, peritumoral and combined radiomics features, respectively, and the radiomics score (Rad-score) were calculated. Kaplan -Meier survival analysis was used to evaluate the relationship between the Rad-score with PFS and OS, the Harrell's concordance index (C -index) was used to evaluate the predictive performance of the radiomics signatures. Results: Finally, 8, 6, and 21 features were selected for the establishment of RS intratumoral, RS peritumoral, and RS combined, respectively. Kaplan -Meier survival analysis confirmed that the Rad-scores of the three RSs were significantly correlated with the PFS and OS of patients with osteosarcoma. Among the three radiomics signatures, RS combined had better predictive performance, the C -index of PSF prediction was 0.833 in the training cohort and 0.814 in the testing cohort, the C -index of OS prediction was 0.796 in the training cohort and 0.764 in the testing cohort. Conclusions: CT -based intratumoral, peritumoral and combined radiomics signatures can predict the prognosis of patients with osteosarcoma, which may assist in individualized treatment and improving the prognosis of osteosarcoma patients.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] CT-based radiomics to predict development of macrovascular invasion in hepatocellular carcinoma: A multicenter study
    Jing-Wei Wei
    Si-Rui Fu
    Jie Zhang
    Dong-Sheng Gu
    Xiao-Qun Li
    Xu-Dong Cheng
    Shuai-Tong Zhang
    Xiao-Fei He
    Jian-Feng Yan
    Li-Gong Lu
    Jie Tian
    Hepatobiliary & Pancreatic Diseases International, 2022, 21 (04) : 325 - 333
  • [32] Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
    Liang Li
    Li Wang
    Feifei Zeng
    Gongling Peng
    Zan Ke
    Huan Liu
    Yunfei Zha
    European Radiology, 2021, 31 : 7901 - 7912
  • [33] Development and multicenter validation of a CT-based radiomics signature for predicting severe COVID-19 pneumonia
    Li, Liang
    Wang, Li
    Zeng, Feifei
    Peng, Gongling
    Ke, Zan
    Liu, Huan
    Zha, Yunfei
    EUROPEAN RADIOLOGY, 2021, 31 (10) : 7901 - 7912
  • [34] CT-based radiomics to predict development of macrovascular invasion in hepatocellular carcinoma: A multicenter study
    Wei, Jing-Wei
    Fu, Si-Rui
    Zhang, Jie
    Gu, Dong-Sheng
    Li, Xiao-Qun
    Chen, Xu-Dong
    Zhang, Shuai-Tong
    He, Xiao-Fei
    Yan, Jian-Feng
    Lu, Li-Gong
    Tian, Jie
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2022, 21 (04) : 325 - 333
  • [35] Intratumoral and Peritumoral Radiomics for Predicting the Prognosis of High-grade Serous Ovarian Cancer Patients Receiving Platinum-Based Chemotherapy
    Huang, Xiaoyu
    Huang, Yong
    Liu, Kexin
    Zhang, Fenglin
    Zhu, Zhou
    Xu, Kai
    Li, Ping
    ACADEMIC RADIOLOGY, 2025, 32 (02) : 877 - 887
  • [36] Dual-phase contrast-enhanced CT-based intratumoral and peritumoral radiomics for preoperative prediction of lymph node metastasis in gastric cancer
    Zhou, Yun-hui
    Chen, Xiao-li
    Zhang, Xin
    Pu, Hong
    Li, Hang
    BMC GASTROENTEROLOGY, 2025, 25 (01)
  • [37] A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma
    Akinari Kasai
    Jinsei Miyoshi
    Yasushi Sato
    Koichi Okamoto
    Hiroshi Miyamoto
    Takashi Kawanaka
    Chisato Tonoiso
    Masafumi Harada
    Masakazu Goto
    Takahiro Yoshida
    Akihiro Haga
    Tetsuji Takayama
    Scientific Reports, 14
  • [38] CT-based delta radiomics in predicting the prognosis of stage IV gastric cancer to immune checkpoint inhibitors
    Li, Jiazheng
    Chen, Zifan
    Chen, Yang
    Zhao, Jie
    He, Meng
    Li, Xiaoting
    Zhang, Li
    Dong, Bin
    Zhang, Xiaotian
    Tang, Lei
    Shen, Lin
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [39] A CT-Based Radiomics Nomogram to Predict Complete Ablation of Pulmonary Malignancy: A Multicenter Study
    Zhang, Guozheng
    Yang, Hong
    Zhu, Xisong
    Luo, Jun
    Zheng, Jiaping
    Xu, Yining
    Zheng, Yifeng
    Wei, Yuguo
    Mei, Zubing
    Shao, Guoliang
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [40] Predicting treatment response and prognosis of immune checkpoint inhibitors-based combination therapy in advanced hepatocellular carcinoma using a longitudinal CT-based radiomics model: a multicenter study
    Xu, Jun
    Li, Junjun
    Wang, Tengfei
    Luo, Xin
    Zhu, Zhangxiang
    Wang, Yimou
    Wang, Yong
    Zhang, Zhenglin
    Song, Ruipeng
    Yang, Li-Zhuang
    Wang, Hongzhi
    Wong, Stephen T. C.
    Li, Hai
    BMC CANCER, 2025, 25 (01)